Wet AMD 3 Symposium

Related

• 

  Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model

  Jennifer I. Lim, MD, FARVO, FASRS

  Updates from the Field

  2021

• 

  Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study

  Mark R. Barakat, MD

  Annual Meeting Talks

  2021

• 

  The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses

  David S. Boyer, MD

  Annual Meeting Talks

  2019